Evidence map›Paper›PMID 30733474›Full record

ArticleScientific reports2019

Molecular interaction of fibrinogen with zeolite nanoparticles.

Hossein Derakhshankhah, Atiyeh Hosseini, Fereshteh Taghavi, Samira Jafari, Alireza Lotfabadi, Mohammad Reza Ejtehadi, Sahba Shahbazi, Ali Fattahi, Atiyeh Ghasemi, Ebrahim Barzegari and 14 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 4 countries.

Hossein DerakhshankhahNano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Atiyeh HosseiniInstitute for Nanoscience and Nanotechnology and Center of Excellence in Complex Systems and Condensed Matter (CSCM), Sharif University of Technology, Tehran, 1458889694, Iran.
Fereshteh TaghaviInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Samira JafariPharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Alireza LotfabadiNano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mohammad Reza EjtehadiDepartment of Physics, Sharif University of Technology, P. O. Box 11155-9161, Tehran, Iran.
Sahba ShahbaziSchool of Biology College of Science, University of Tehran, Tehran, Iran.
Ali FattahiPharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Atiyeh GhasemiInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Ebrahim BarzegariPharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mina EviniInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Ali Akbar SabouryInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Seyed Mehdi Kamali ShahriDepartment of Chemical Engineering, Pennsylvania State University, University Park, PA, 16802, United States.
Behnaz GhaemiDepartment of Medical Nanotechnology, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, 1417755469, Iran.
Eng-Poh NgSchool of Chemical Sciences, Universiti Sains Malaysia, Gelugor, 11800 USM, Malaysia.
Hussein AwalaLaboratory of Catalysis and Spectroscopy, ENSICAEN, University of Caen, CNRS, 6 Boulevard du Marechal Juin, 14050, Caen, France.
Fatemeh OmraniPersian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, 75147, Iran.
Iraj NabipourPersian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, 75147, Iran.
Mohammad RaoufiNanotechnology Research Center, Faculty of Pharmacy, Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 13169-43551, Iran.
Rassoul DinarvandNanotechnology Research Center, Faculty of Pharmacy, Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 13169-43551, Iran.
Koorosh ShahpasandDepartment of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Svetlana MintovaLaboratory of Catalysis and Spectroscopy, ENSICAEN, University of Caen, CNRS, 6 Boulevard du Marechal Juin, 14050, Caen, France. mintova@ensicaen.fr.
Mohammad Javad HajipourPersian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, 75147, Iran. mj.hajipour@ncdrc.info.
Morteza MahmoudiDepartment of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, United States. mmahmoudi@bwh.harvard.edu.
Kermanshah University of Medical Sciences · IRUniversity of Tehran · IRBiotechnology Research Center · IRTehran University of Medical Sciences · IRSharif University of Technology · IRUniversité de Caen Normandie · FRAcademic Center for Education, Culture and Research · IRBrigham and Women's Hospital · USPennsylvania State University · USUniversiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrinogen is one of the key proteins that participate in the protein corona composition of many types of nanoparticles (NPs), and its conformational changes are crucial for activation of immune systems. Recently, we demonstrated that the fibrinogen highly contributed in the protein corona composition at the surface of zeolite nanoparticles. Therefore, understanding the interaction of fibrinogen with zeolite nanoparticles in more details could shed light of their safe applications in medicine. Thus, we probed the molecular interactions between fibrinogen and zeolite nanoparticles using both experimental and simulation approaches. The results indicated that fibrinogen has a strong and thermodynamically favorable interaction with zeolite nanoparticles in a non-cooperative manner. Additionally, fibrinogen experienced a substantial conformational change in the presence of zeolite nanoparticles through a concentration-dependent manner. Simulation results showed that both E- and D-domain of fibrinogen are bound to the EMT zeolite NPs via strong electrostatic interactions, and undergo structural changes leading to exposing normally buried sequences. D-domain has more contribution in this interaction and the C-terminus of γ chain (γ

Indexed as

Chemical PhenomenaModels, MolecularBinding SitesFibrinogenHumansMetal NanoparticlesMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureNanoparticlesProtein BindingSpectrum AnalysisThermodynamicsZeolitesFibrinogenZeolites

Identifiers

PMID30733474
PMCPMC6367512
OpenAlexW2914560048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.